GAE, or genicular artery embolization, is a minimally invasive procedure that reduces chronic knee pain by cutting off blood supply to inflamed tissue inside the joint. It targets the abnormal blood vessels that fuel inflammation in knee osteoarthritis, and studies show it can reduce pain scores by roughly 67% at one year. The procedure is done through a tiny puncture in the leg, takes about an hour, and you go home the same day.
How GAE Works
In a knee with osteoarthritis, the lining of the joint (called the synovium) and the bone just beneath the cartilage develop networks of new, abnormal blood vessels. These vessels aren’t helpful. They feed a cycle of inflammation, delivering immune cells and inflammatory signals that keep the joint swollen and painful. They also carry nerve fibers that amplify pain signaling to the brain.
GAE interrupts this cycle. A doctor threads a thin catheter through an artery in the leg, guided by real-time X-ray imaging, until it reaches the small genicular arteries that supply the knee. Once in position, tiny particles are injected to block these vessels. With the blood supply to inflamed tissue reduced, the inflammation quiets down and so does the pain. The rest of the knee’s blood supply remains intact.
The particles used come in two broad categories: temporary agents that dissolve over weeks, and permanent microspheres that stay in place. Temporary agents tend to cause fewer skin-related side effects, though no consensus exists yet on which type is ideal.
What the Procedure Feels Like
GAE is performed under light sedation, not general anesthesia. A doctor makes a small puncture, typically near the upper thigh, to access an artery. From there, a catheter about the width of a piece of spaghetti is guided down to the knee’s blood vessels. Contrast dye is injected so the doctor can see the arteries on a screen and identify the ones feeding inflamed tissue. The blocking particles are then delivered through the catheter.
The whole process is outpatient. You go home the same day once the sedation wears off. Most people need to limit physical activity for about a week afterward, but recovery is far less involved than surgical options like knee replacement. There are no incisions to heal and no need for crutches or physical therapy in most cases.
How Well It Works
In a study published in JBJS Open Access, patients saw their overall knee function scores improve by 61% and their pain scores drop by 67% at 12 months. About 68% of patients achieved at least a 50% reduction in both pain and overall symptoms, a threshold considered clinically meaningful.
Longer-term data from a two-year prospective trial offers a clearer picture of durability. Among patients who responded well at one year, 72% maintained that relief at the two-year mark. The other 28% experienced some return of symptoms between months 12 and 24. Looking at all patients treated (including those who didn’t respond initially), 47% still had successful outcomes at two years. These numbers suggest GAE works best as a durable solution for people whose knees respond in the first year, though it’s not a permanent fix for everyone.
Who Is a Good Candidate
GAE is primarily used for people with knee osteoarthritis who haven’t gotten adequate relief from conservative treatments like physical therapy, anti-inflammatory medications, or injections (corticosteroids, hyaluronic acid, or platelet-rich plasma). It’s particularly appealing for people who want to delay or avoid knee replacement surgery, or who aren’t good surgical candidates due to age, weight, or other health conditions.
The procedure works by targeting inflammation, so it tends to perform best in knees where inflammation is a significant driver of pain rather than purely mechanical problems like bone-on-bone grinding in very advanced arthritis. Patients with mild to moderate osteoarthritis have shown the most consistent results in clinical studies, though people with more severe disease have also benefited.
Risks and Side Effects
GAE has a strong safety record so far. No serious adverse events like joint instability, muscle weakness, or permanent tissue damage have been reported in the published literature. All recorded complications have been minor and self-limiting.
The most common side effect is temporary skin changes near the knee, which happen when the tiny blocking particles inadvertently reach small blood vessels supplying the skin. This can show up as redness or, less commonly, small surface-level skin irritation. Depending on the type of particle used, skin changes occur in anywhere from 2.5% to 65% of cases. Temporary embolic agents cause far fewer of these issues (around 2.5%) compared to permanent microspheres (up to 63%), and when they do occur with temporary agents, they typically resolve in about three weeks rather than the 4 to 12 weeks sometimes seen with permanent particles.
Small bruises at the catheter insertion site in the thigh occur in up to 17% of cases but resolve on their own. Mild post-procedure fever is rare, with only a single case reported across multiple studies.
Insurance Coverage
Coverage for GAE is evolving. For years, most insurers considered it experimental, leaving patients to pay out of pocket (costs typically range from $5,000 to $15,000 depending on the facility). That picture is starting to shift. Kaiser Permanente Washington, for example, updated its criteria effective April 2026 to include GAE for knee osteoarthritis under its medical necessity guidelines, though prior authorization is required across all their plan types.
If you’re considering GAE, check with your insurance provider before scheduling. Ask specifically whether genicular artery embolization is covered under your plan and whether prior authorization is needed. The procedure is increasingly available at major medical centers with interventional radiology departments, particularly at academic hospitals and large health systems.
GAE Compared to Other Options
GAE fills a gap between conservative treatments and surgery. Steroid injections offer temporary relief but typically wear off in weeks to months and can’t be repeated indefinitely without risking cartilage damage. Nerve ablation procedures (genicular nerve blocks or radiofrequency ablation) target pain signals rather than inflammation, and their effects often fade within 6 to 12 months. Knee replacement is highly effective but involves major surgery, months of rehabilitation, and carries risks that increase with age and other health conditions.
GAE addresses the underlying inflammation driving the pain, not just the pain signals. It requires no general anesthesia, no hospital stay, and about a week of limited activity. For people stuck between injections that aren’t cutting it and a surgery they’re not ready for, GAE offers a middle path with meaningful, multi-year pain relief for the majority of responders.